BlackRock Advisors’s Opus Genetics IRD Stock Holding History

BlackRock Advisors’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$6K	Hold	93	–	–	﹤0.01%	3619
2016 Q3	$9K	Hold	93	–	–	﹤0.01%	3590
2016 Q2	$11K	Hold	93	–	–	﹤0.01%	3566
2016 Q1	$15K	Hold	93	–	–	﹤0.01%	3504
2015 Q4	$16K	Hold	93	–	–	﹤0.01%	3550
2015 Q3	$23K	Hold	93	–	–	﹤0.01%	3484
2015 Q2	$27K	Buy	93 +18	+24%	+$6.11K	﹤0.01%	3428
2015 Q1	$26K	Hold	75	–	–	﹤0.01%	3396
2014 Q4	$25K	Hold	75	–	–	﹤0.01%	3450
2014 Q3	$29K	Hold	75	–	–	﹤0.01%	3409
2014 Q2	$31K	Hold	75	–	–	﹤0.01%	3348
2014 Q1	$39K	Buy	75 +39	+108%	+$21.1K	﹤0.01%	3301
2013 Q4	$9K	Hold	36	–	–	﹤0.01%	3520
2013 Q3	$8K	Hold	36	–	–	﹤0.01%	3497
2013 Q2	$8K	Buy	+36	New	+$6.18K	﹤0.01%	3464

Other funds holding IRD

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HVIA

Hudson Valley Investment Advisors Goshen, New York $823M AUM 31.4% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock Advisors's IRD Position: Q4 2016 in Review

BlackRock Advisors held its Opus Genetics (IRD) position steady in Q4 2016 at 93 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #3619.

BlackRock Advisors first reported a position in IRD in Q2 2013 and has held it in 15 quarters since. The position peaked at $39K in Q1 2014. 31 funds tracked by Wall St. Rank hold IRD as of Q4 2016.

BlackRock Advisors held 93 shares of Opus Genetics worth $6K as of Q4 2016.
BlackRock Advisors left its Opus Genetics share count unchanged in Q4 2016.
Opus Genetics made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3619 holding.
BlackRock Advisors first reported a position in Opus Genetics in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's Opus Genetics position peaked at $39K in Q1 2014.
31 funds tracked by Wall St. Rank held Opus Genetics as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.